
Study suggests lean muscle mass loss can be minimized during weight loss therapy using newer incretin obesity drugs
New research to be presented at the European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for weight loss experienced minimal […]